Literature DB >> 9463924

Carcinogenicity studies on MTBE: critical review and interpretation.

J H Mennear1.   

Abstract

Chronic inhalation of toxic concentrations of MTBE caused renal tubular cell neoplasms in male Fischer 344 rats and hepatocellular adenomas in female CD-1 mice. In Sprague-Dawley rats the oral administration of MTBE was associated with increased incidences of Leydig cell tumors and of lymphomas and leukemias (combined) in males and females, respectively. Neither lymphomas nor leukemias were individually increased in treated females. leydig cell tumors are common in rats and do not predict human responses to drugs and chemicals. Neither MTBE nor its metabolite, t-butyl alcohol, possess mutagenic potential and a second metabolite, formaldehyde, is mutagenic in vitro but in vivo results are equivocal. MTBE-induced neoplasms are most likely produced through a nongenetic mechanism which requires chronic exposure to toxic doses. Because of the intense odor (and taste) of MTBE, humans will not tolerate either air or water concentrations sufficient to produce the cytotoxic precursors required to promote cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463924     DOI: 10.1111/j.1539-6924.1997.tb01274.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  3 in total

1.  Chronic carcinogenicity study of gasoline vapor condensate (GVC) and GVC containing methyl tertiary-butyl ether in F344 rats.

Authors:  Janet M Benson; Andrew P Gigliotti; Thomas H March; Edward B Barr; Brad M Tibbetts; Betty J Skipper; Charles R Clark; Lorraine Twerdok
Journal:  J Toxicol Environ Health A       Date:  2011

Review 2.  Overview of Emerging Contaminants and Associated Human Health Effects.

Authors:  Meng Lei; Lun Zhang; Jianjun Lei; Liang Zong; Jiahui Li; Zheng Wu; Zheng Wang
Journal:  Biomed Res Int       Date:  2015-12-02       Impact factor: 3.411

3.  Hazardous air pollutants and primary liver cancer in Texas.

Authors:  Luca Cicalese; Giuseppe Curcuru; Mauro Montalbano; Ali Shirafkan; Jeremias Georgiadis; Cristiana Rastellini
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.